Metformin in the Diastolic Dysfunction of Metabolic Syndrome: MET-DIME Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Metformin (Primary)
- Indications Diastolic heart failure; Left ventricular dysfunction; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms MET-DIME
- 10 Jun 2017 Biomarkers information updated
- 19 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Dec 2015 Planned End Date changed from 1 Oct 2016 to 1 Nov 2017as reported by ClinicalTrials.gov record.